Cover Image

Galectin-1 promotes HIV-1 latency reactivation

Saved in:

Bibliographic Details
Main Authors:	J. Rubione (Author), G. Duette (Author), P. Perez (Author), P. Pereyra Gerber (Author), J. Salido (Author), A. Cagnoni (Author), L. Guzman (Author), A. Adamczyk (Author), O. Sued (Author), Y. Ghiglione (Author), N. Laufer (Author), K. Mariño (Author), G. Rabinovich (Author), M. Ostrowski (Author)
Format:	Book
Published:	Elsevier, 2019-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

PP 1.1 - 00009 TB-associated microenvironment promotes HIV latency in CD4+ T cells
by: G. Duette, et al.
Published: (2022)

Early skewed differentiation and PD-1 expression in CD4+ cells relate to immune dysfunction and viral persistence in individuals living with HIV 1 year post-cART initiation
by: J. Salido, et al.
Published: (2019)

Phenotype and functionality of CD8+ T cells before and after cART are related to the viral reservoir size in people living with HIV-1
by: A. Czernikier, et al.
Published: (2019)

Circulating Galectin-1 and Galectin-3 in Sera From Patients With Systemic Sclerosis: Associations With Clinical Features and Treatment
by: Victoria Sundblad, et al.
Published: (2021)

Latency reactivating agents: impact on human macrophages physiology and susceptibility to HIV-1 infection
by: L. Hany, et al.
Published: (2019)

Galectin-1 Facilitates Macrophage Reprogramming and Resolution of Inflammation Through IFN-β
by: Hiba Yaseen, et al.
Published: (2020)

OA2-1 Frequent and 'burst-like' reactivation from latency in SIVmac239M infected macaques
by: M. Pinkevych, et al.
Published: (2016)

Galectin-1 as an Emerging Mediator of Cardiovascular Inflammation: Mechanisms and Therapeutic Opportunities
by: Ignacio M. Seropian, et al.
Published: (2018)

Degradation of the XPB subunit of TFIIH by spironolactone reduces HIV-1 reactivation from latency
by: L. Mori, et al.
Published: (2019)

Human galectin-9 is a potent mediator of HIV transcription and reactivation
by: M. Abdel-Mohsen, et al.
Published: (2015)

The steroid receptor coactivators are targets for reactivation of HIV latency
by: B.C. Nikolai, et al.
Published: (2015)

Galectin-1 Prevents Infection and Damage Induced by Trypanosoma cruzi on Cardiac Cells.
by: Alejandro F Benatar, et al.
Published: (2015)

Reactivation capacity by latency reversing agents ex vivo correlates with the size of the HIV-1 reservoir
by: Gilles Darcis, et al.
Published: (2016)

The efficacy and tolerability of latency-reversing agents in reactivating the HIV-1 reservoir in clinical studies: a systematic review
by: Quinten Debrabander, et al.
Published: (2023)

Evolutionary analysis of galectins and identification of potential galectin-1 inhibitors: A computational approach
by: Vipperla Bhavaniprasad, et al.
Published: (2014)

Evolutionary analysis of galectins and identification of potential galectin-1 inhibitors: A computational approach
by: Vipperla Bhavaniprasad, et al.
Published: (2014)

Visualisation of HIV reactivation from latency in primary resting memory T-cells
by: F. Kizito, et al.
Published: (2019)

Optimisation of Smac mimetics as HIV-1 latency reversing agents
by: L. Pache, et al.
Published: (2019)

4 New HIV specific latency reversing agents with novel targets that synergise with HIV Tat and the bromodomain inhibitor, JQ1 to reactivate HIV from primary cells.
by: J. Jacobson, et al.
Published: (2017)

Human endogenous retrovirus expression landscape in models of HIV-1 latency
by: M. de Mulder Rougvie, et al.
Published: (2019)

O6 Reactivation capacity by latency reversing agents ex vivo correlates with the size of the HIV-1 reservoir
by: Gilles Darcis, et al.
Published: (2016)

A Pro-resolving Role for Galectin-1 in Acute Inflammation
by: Hannah L. Law, et al.
Published: (2020)

20 Sirtuin1 inhibitor nicotinamide disrupts HIV-1 latency
by: S. Samer, et al.
Published: (2016)

24 Thalidomide reverses latency of HIV-1 provirus
by: S. Samer, et al.
Published: (2016)

Galectin-1 as a predictive biomarker in ovarian cancer
by: Mahak Masoodi, et al.
Published: (2021)

The HIV-1 antisense transcript AST is an inducer of viral latency
by: F. Romerio, et al.
Published: (2015)

25 Targeting HSF1-mediated stress response can enhance Hsp90 inhibitor-induced suppression of HIV-1 reactivation from latency
by: A. Kabakov, et al.
Published: (2016)

23 Understanding the effects of latency reversing agents on HIV RNA splicing: implications for latency reversal
by: T.M. Mota, et al.
Published: (2016)

Hormonal control of HIV-1 latency by estrogen imparts gender-specific restrictions on the latent reservoir
by: J. Karn, et al.
Published: (2019)

10 The interferon-inducible restriction factor TRIM22 contributes to HIV-1 latency
by: F. Turrini, et al.
Published: (2016)

Identification of isoform-selective hydroxamic acid derivatives that potently reactivate HIV from latency
by: Elleard F.W. Heffern, et al.
Published: (2019)

Mixed effects of HDACi on host gene expression and their implications for HIV reactivation from latency
by: N. Beliakova-Bethell, et al.
Published: (2015)

PP 1.4 - 00037 Histone decrotonylation uniquely regulates HIV-1 transcription and can be modulated to control HIV-1 latency
by: T.L. Simermeyer, et al.
Published: (2022)

HIV-1 transcriptional latency in resting CD4 T-cell
by: M. Benkirane
Published: (2015)

13 HIV-1-specific ADCC following anti-latency therapy and analytical treatment interruption
by: W.S. Lee, et al.
Published: (2017)

Using single-cell analysis and a primary model of HIV to study latency establishment and reactivation
by: L. De Armas, et al.
Published: (2019)

Galectins and galectin-mediated autophagy regulation: new insights into targeted cancer therapy
by: Dan Liu, et al.
Published: (2023)

Cell Biology of Galectins
Published: (2022)

Galectins and cutaneous immunity
by: Huan-Yuan Chen, et al.
Published: (2012)

Towards achieving a state of reversible HIV-1 latency in primary monocyte-derived macrophages (MDM) by M1 polarization
by: G. Poli, et al.
Published: (2015)